- Home
- SWVL vs DYAI Comparison
SWVL vs DYAI Comparison
Compare SWVL & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SWVL | DYAI |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 29.9M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | SWVL | DYAI |
|---|---|---|
| Price | $1.80 | $0.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 12.6K | ★ 57.4K |
| Earning Date | 09-08-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,329,423.00 | $3,342,195.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | N/A | $92.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.81 | $0.71 |
| 52 Week High | $5.55 | $1.73 |
Technical Indicators
Market Signals| Indicator | SWVL | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 35.52 | 43.49 |
| Support Level | $2.25 | $0.87 |
| Resistance Level | $2.50 | $0.95 |
| Average True Range (ATR) | 0.21 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 4.85 | 24.73 |
Price Performance
Historical ComparisonAbout SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.